ORCHARD THERAPEUTICS PLC Earnings Per Share (Diluted)
ORCHARD THERAPEUTICS PLC reported Earnings Per Share (Diluted) of -$0.15 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC earnings per share, diluted for the quarter ending 2023-09-30 was -$0.15.
- ORCHARD THERAPEUTICS PLC earnings per share, diluted for the quarter ending 2023-06-30 was -$0.07.
- ORCHARD THERAPEUTICS PLC earnings per share, diluted for the quarter ending 2023-03-31 was -$0.12.
- ORCHARD THERAPEUTICS PLC earnings per share, diluted for the quarter ending 2022-12-31 was $0.00.
- ORCHARD THERAPEUTICS PLC earnings per share, diluted for fiscal 2022 was -$1.18.
- ORCHARD THERAPEUTICS PLC earnings per share, diluted for fiscal 2021 was -$1.17.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$0.15 10-Q · filed 2023-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.35 10-Q · filed 2023-11-13 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2023-06-30 | -$0.07 10-Q · filed 2023-08-10 | -$0.18 10-Q · filed 2023-08-10 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2023-03-31 | -$0.12 10-Q · filed 2023-05-15 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-12-31 | $0.00 derived: net income ÷ weighted average shares · filed 2023-03-14 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.18 10-K · filed 2023-03-14 |
| 2022-09-30 | -$0.37 10-Q · filed 2023-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.12 10-Q · filed 2023-11-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-06-30 | -$0.40 10-Q · filed 2023-08-10 | -$0.75 10-Q · filed 2023-08-10 | -$1.03 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.32 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-03-31 | -$0.35 10-Q · filed 2023-05-15 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.21 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2021-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.86 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$1.17 10-K · filed 2023-03-14 |
| 2021-09-30 | -$0.29 10-Q · filed 2022-11-14 | -$0.58 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.88 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$0.29 10-Q · filed 2022-08-04 | -$0.60 10-Q · filed 2022-08-04 |